INR:1547. best time pass games New drug for neuroblastoma! Y-mAbs company naxitamab applies for listing in the United States 4 patients tested positive for n ...
Inhibitor Therapeutics, Inc. (OTCMKTS:INTI – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest ...
AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...
The City of Grand Junction announced it is constructing two new Level 2 Electric Vehicle charging stations and has replaced three city-owned charging facilities with new software, EvGateway.
Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric ...